Trials / Completed
CompletedNCT05872087
Comparative Study Between Nebulised Dexmedetomidine and Nebulised Midazolam in Children Undergoing Lower Abdominal Surgeries
Comparative Study Between Nebulised Dexmedetomidine and Nebulised Midazolam in Reducing Preoperative Anxiety and Emergence Delirium in Children Undergoing Lower Abdominal Surgeries
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- All
- Age
- 3 Years – 8 Years
- Healthy volunteers
- Accepted
Summary
Comparative study between nebulised dexmedetomidine and nebulized midazolam in reducing preoperative anxiety and emergence delirium in children undergoing lower abdominal surgeries
Detailed description
Dexmedetomidine is widely used in children and is replacing midazolam as the drug of choice for preoperative anxiolysis and sedation. However, there are limited studies comparing nebulized route in reducing preoperative anxiety and emergence delirium in children undergoing lower abdominal surgeries
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nebulised Dexmeditomidine | premedication by dexmeditomidine 3mcg/kg in children undergoing lower abdominal surgeries |
| DRUG | Nebulised Midazolam | premedication by nebulised midazolam 0.3mg/kg in children undergoing lower abdominal surgeries |
Timeline
- Start date
- 2022-11-01
- Primary completion
- 2023-09-01
- Completion
- 2024-02-01
- First posted
- 2023-05-24
- Last updated
- 2024-05-24
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05872087. Inclusion in this directory is not an endorsement.